Maternal undernutrition reduces P-glycoprotein in guinea pig placenta and developing brain in late gestation

Poh S Soo1, Jennifer Hiscock, Kimberley J Botting

  • 1Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, SA 5001, Australia.

Insights

Maternal undernutrition in guinea pigs reduced placental P-glycoprotein (P-gp) and fetal brain P-gp protein expression, potentially altering drug transfer to the fetus.

Area of Science:

  • Obstetrics and Gynecology
  • Developmental Biology
  • Pharmacology

Background:

  • Poor maternal nutrition is a significant factor in fetal growth restriction, leading to increased neonatal complications and long-term health risks.
  • P-glycoprotein (P-gp) plays a crucial role in regulating the transport of substances across biological barriers, including the placenta.

Purpose of the Study:

  • To investigate the impact of maternal undernutrition on P-glycoprotein (P-gp) expression in the placenta and the brains of both mother and fetus.
  • To understand how maternal nutritional status influences placental drug transfer capabilities.

Main Methods:

  • Guinea pigs were subjected to an undernutrition regimen.
  • Placental and brain tissues from both mothers and fetuses were analyzed for P-gp protein and MDR1 mRNA expression.
  • Capillary density in placental and fetal brain tissues was assessed.

Main Results:

  • Maternal undernutrition led to placental restriction and reduced fetal weight.
  • A significant decrease in P-gp protein expression was observed in the placenta and fetal brain, but not the maternal brain.
  • While mRNA levels were unchanged, protein levels indicate altered P-gp function.

Conclusions:

  • Maternal undernutrition significantly downregulates P-gp protein expression in the placenta and fetal brain.
  • These changes may affect the transfer of drugs from mother to fetus, influencing fetal exposure during pregnancy.
  • Further research is needed to elucidate the clinical implications for drug therapy in undernourished pregnant individuals.